Amgen Inc. has agreed to a $71 million settlement with 48 state attorneys general who accused the drugmaker of marketing its anemia drug Aranesp and plaque psoriasis drug Enbrel, both biolog... Read more
The U.S. Department of Justice has reached a settlement with Amgen over alleged kickback payments tied to its anemia drug. It was reported that the biotech drug maker will pay $24.9 million... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.